Spermosens
0.008
SEK
+5.13 %
Less than 1K followers
SPERM
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.
Read moreMarket cap
21.86M SEK
Turnover
58.44K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
20/8
2025
Interim report Q2'25
12/11
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
Spermosens AB Announces Results from Annual General Meeting on 16 June 2025
Chairman and CEO of Spermosens exercise TO5 warrants
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools